USPTO serial 79316852
PROSTROLANE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- JOHNSON, BRITTANY S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PROSTROLANE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of knee joint inflammation, namely, fillers for inflammation of the knee joint; medicines for human purposes, namely, medicinal preparations for the treatment of knee joint inflammation; pharmaceutical preparations for dermatological use; pharmaceutical preparations for the care of the skin; pharmaceutical preparations for the treatment of knee joint inflammation; non-prescription medicines, namely, medicinal preparations for the treatment of the skin and for dermatological use; non-prescription medicines, namely, medicinal preparations for the treatment of knee joint inflammation; skin care preparations for medical purposes; pharmaceutical products for the treatment of bone diseases; acne medication; implants comprising living tissue; medicines for dental purposes; prosthesis material for dental purposes, namely, porcelain for dental prostheses; filled syringes sold filled with dermatological preparations for medical purposes; pharmaceuticals, namely, pre-filled syringes used for filling wrinkles, folds, scars, lips for face and body contouring and for skin rejuvenation, and used for treatment of inflammation of knee joints; pharmaceuticals, namely, pre-filled syringes used for skin fillers; injectable dermal fillers for use in the treatment of cellulite, folds, scars, and body contouring and for rejuvenating the skin; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient | ACTIVE | — |
| 010 | Implants consisting of artificial materials; implants consisting of artificial materials in gel form; implants consisting of artificial materials, namely, a polymer gel for filling wounds and lips, contouring the face and body, and rejuvenating the skin; implants consisting of artificial materials, namely, a polymer gel used for wrinkle and scar treatment, lip, face, body contour and skin medical apparatus, namely, syringes for injecting fillers; medical prostheses, namely, joint prostheses; medical apparatus, namely, infusion and injection devices for injecting fillers; implantable subcutaneous drug delivery devices in the nature of implantable drug delivery ports | ACTIVE | — |
| 035 | Retail store services featuring chemical preparations for use in industry; wholesale store services featuring chemical preparations for use in industry; sales agency services, namely, retail services by direct solicitation by sales agents in the field of chemical preparations for use in industry; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring medical apparatus and instruments other than for dental purposes; sales agency services, namely, retail services by direct solicitation by sales agents in the field of medical apparatus and instruments other than for dental purposes; retail store services featuring human and animal drugs; sales agency services, namely, retail services by direct solicitation by sales agents in the field of human and animal drugs; wholesale store services featuring human and animal drugs; promoting the goods and services of others by means of operating an on-line comprehensive shopping mall; business intermediary services relating to mail order by telecommunications, namely, order fulfillment services; wholesale store services featuring cosmetics; retail store services featuring cosmetics; retail store services featuring biochemical additive for cosmetics manufacturing; wholesale store services featuring biochemical additive for cosmetics manufacturing; sales agency services, namely, retail services by direct solicitation by sales agents in the field of biochemical additive for cosmetics manufacturing; retail store services featuring peptide for cosmetics manufacturing; wholesale store services featuring peptide for cosmetics manufacturing; sales agency services, namely, retail services by direct solicitation by sales agents in the field of peptide for cosmetics manufacturing; sales agency services, namely, retail services by direct solicitation by sales agents in the field of cosmetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks owned by CAREGEN CO., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named PROSTROLANE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 14, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 20, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 27, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 26, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 29, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |